Wall Street Journal Examines Pharmaceutical Industry Reconsideration of Television Advertisements
Main Category: Pharma Industry / Biotech IndustryArticle Date: 17 May 2005 - 11:00 PDT
| Patient / Public: | ![]() | |
| Healthcare Prof: | ![]() |
The Wall Street Journal on Monday examined the pharmaceutical industry's "modest move away" from television advertising as "some drug makers are concluding that they have overspent and are scaling back." According to the... Journal, the "rethinking at some companies" -- including Pfizer, TAP Pharmaceuticals and AstraZeneca -- "reflects a sharper focus on the return on money spent as well as an increasing public and regulatory backlash against" television ads for prescription drugs. Collectively, the industry spent $4.45 billion on advertising in all media in 2004, a 23% increase over 2003 spending. However, companies are finding that prescription drugs sales "don't necessarily rise or fall as TV ads are boosted or reduced" because consumers often "ignore the spots, pass over them with personal video recorders ... or skip" television "altogether to surf the Internet," the Journal reports. Some advertisers say other media, such as magazines or the Internet, "allow deeper communication with consumers than TV, particularly on drug features and risks," according to the Journal. Stuart Klein -- president of Quantum, a unit of the advertising firm WPP Group that specializes in health care products -- said, "What I'm seeing is the recognition by companies that the last 5% to 10% of TV spending is much better spent on relationship marketing or on the Internet, where you can have a deeper dialogue with people." IMS Health drug marketing consultant David Gascoigne said, "I think the $100 million branded TV advertising campaigns are over." He added that television spending likely will "plateau and possibly decline in the near term." The Journal reports that "even a small change in strategy by drug makers ... could have outsized implications for the medium" and "buoy the fortunes of alternative outlets" (Hensley, Wall Street Journal, 5/16).
"Reprinted with permission from kaisernetwork.org kaisernetwork.org. You can view the entire Kaiser Daily Health Policy Report, search the archives, or sign up for email delivery at http://www.kaisernetwork.org/dailyreports/healthpolicy. The Kaiser Daily Health Policy Report is published for kaisernetwork.org, a free service of The Henry J. Kaiser Family Foundation . © 2005 Advisory Board Company and Kaiser Family Foundation. All rights reserved.
Visit our pharma industry / biotech industry section for the latest news on this subject.
MLA
15 Feb. 2012. <http://www.medicalnewstoday.com/releases/24558.php>
APA
http://www.medicalnewstoday.com/releases/24558.php.
Please note: If no author information is provided, the source is cited instead.
|
Rate this article: (Hover over the stars then click to rate) |
Patient / Public: |
or |
Health Professional: |
Add Your Opinion
Please note that we publish your name, but we do not publish your email address. It is only used to let you know when your message is published. We do not use it for any other purpose. Please see our privacy policy for more information.
If you write about specific medications or operations, please do not name health care professionals by name.
All opinions are moderated before being included (to stop spam)
Contact Our News Editors
For any corrections of factual information, or to contact the editors please use our feedback form.
![]()
Please send any medical news or health news press releases to:
Note: Any medical information published on this website is not intended as a substitute for informed medical advice and you should not take any action before consulting with a health care professional. For more information, please read our terms and conditions.



